Clinical Trial Update: Randomized Controlled Trial Examining the Efficacy of Botulinum Toxin in Biopsy Scar Minimization [Phase 2, Phase 3]

View source ↗

Summary

A randomized controlled trial is evaluating the efficacy of botulinum toxin to minimize biopsy-related scars in patients with scars and hypertrophic scars. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Scar
• Scar

Drugs mentioned

• OnabotulinumtoxinA (botulinum toxin type A)

Snippet

Sponsor: Henry Ford Health System | Conditions: Scar, Hypertrophic Scar | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING